000 01670nam  2200397zi 4500
0019.940306
003CaOODSP
00520240801093551
006m     o  d f      
007cr |n|||||||||
008240709s2007    oncd    o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
041 |aeng|bfre
043 |an-cn---
0861 |aH14-632/2007E-PDF
24500|aAdverse reaction reporting - survey with health professionals : |bfinal report / |cprepared for Health Canada [by] Environics Research Group.
264 1|a[Ottawa] : |b[Health Canada], |c2007.
300 |a1 online resource (1 volume (various pagings)) : |bcharts + |eexecutive summary (4 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"POR 432-06."
500 |a"HC POR 06-93."
500 |a"Delivery date: May 2007."
500 |a"Contract # H1011-060075//001/CY."
546 |aIncludes some text in French.
650 0|aDrugs|xSide effects|xReporting|zCanada|xPublic opinion.
650 0|aMedical personnel|zCanada|xAttitudes.
650 0|aPublic opinion|zCanada.
650 6|aPharmacovigilance|zCanada|xOpinion publique.
650 6|aPersonnel médical|zCanada|xAttitudes.
650 6|aOpinion publique|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aEnvironics Research Group, |econsultant.
85640|qPDF|s814 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-632-2007-eng.pdf|zFinal report
85640|qPDF|s116 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-632-2007-1-eng.pdf|zExecutive summary